期刊文献+

Prognostic factors in 408 elderly lung cancer patients over 70 years old

408例70岁以上老年肺癌患者的预后因素分析(英文)
下载PDF
导出
摘要 Objective: The incidence and mortality of lung cancer in people over 70 years were increased in the past 10 years. We defined age 70 years as boundary line of the elderly patients in lung cancer and analyzed and identified the factors affecting prognosis. Methods: A retrospective study had enrolled 408 cases of lung cancer aged over 70 years old and SPSS13.0 software was used in univariate analysis and COX regression analysis to analyze factors affecting prognosis, such as gender, age, complications, symptoms, pathological type, clinical stage, effusion, surgery, radiotherapy, chemotherapy and so on. Results: In univariate analysis, symptoms, stage, effusion, surgery, chemotherapy and chemotherapy cycles showed affecting prognosis significantly. In COX regression analysis, it showed that clinical stage (P = 0.000), surgery (P = 0.013), chemotherapy cycles (P = 0.001) were independent prognostic factors. Conclusion: Elderly lung cancer patients could be benefit from surgery and adjuvant chemotherapy while early stage. At late stage, their survival time may be prolonged when receive chemotherapy at least 4 cycles. Single-agent chemotherapy would be a good choice for elderly lung cancer. Effusion, particularly, pericardial effusion significantly influenced the prognosis, so that it should be effectively controlled.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2012年第12期699-704,共6页 中德临床肿瘤学杂志(英文版)
关键词 lung neoplasm GERIATRICS PROGNOSIS 预后 肺癌 患者 单因素分析 外科手术 心包积液 老人 回归分析
  • 相关文献

参考文献3

二级参考文献66

  • 1孙清,华军,王琦,徐伟,毛永杰.吉西他滨加或不加顺铂治疗老年人晚期非小细胞肺癌的随机对照研究[J].中华老年医学杂志,2006,25(5):354-355. 被引量:7
  • 2Lsakin JJ, Sandier AB. First-line treatment for advanced non- small-cell lung cancer. Oncology ( Williston Park), 2005, 19 : 1671-1676.
  • 3Gridelli C, Perrone F, Gallo C, et al. Chemotherapy for elderly patients with advanced nonsmall cell lung Cancer: The Mtdticenter Italian Lung Cancer in Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst, 2003, 95 : 362- 372.
  • 4Langer CJ, Manola J, Bemardo P, et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst, 2002, 94: 173-181.
  • 5Costa GJ, Fernandes AL, Pereira JR, et al. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer ( NSCLC ). Lung Cancer, 2006, 53: 171-176.
  • 6Belani CP, Fossella F. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced non- small-cell lung carcinoma (TAX326). Cancer, 2005, 104: 2766- 2774.
  • 7Bianco V, Rozzi A, Tonini G, et al. Gemcitabine as single agent chemotheraphy in elderly patients with stages III-IV non-small cell lung cancer(NSCLC) : a phase II study. Anticanccr Res, 2002, 22:3053-3056.
  • 8Martoni A, Di Fabio F, Guaraldi M, et al. Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage III B/IV non-small-cell lung cancer. Am J Clin Oncol, 2001, 24: 6144517.
  • 9Kortsik C, Albrecht P, Elmer A. Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase II study. Lung Cancer, 2003, 40: 85-90.
  • 10Goldstraw P, Crowley JJ; On behalf of the IASLC International Staging Project. The international association for the study of lung cancer international staging project on lung cancer. J Thorac Oncol 2006; 1:281-286.

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部